Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a hold rating on the stock. Tonix Pharmaceuticals Stock Up 1.3 % NASDAQ TNXP opened at $0.42 on Wednesday. The stock has a market capitalization of $9.91 million, a PE […]

Related Keywords

,Zembrace Symtouch ,Tonix Pharmaceuticals ,Virtu Financial ,Raymond James Associates ,News Ratings For Tonix Pharmaceuticals Daily ,Tonix Pharmaceuticals Stock ,Millennium Management ,Institutional Trading Of Tonix Pharmaceuticals ,Tonix Pharmaceuticals Holding Corp ,Free Report ,Get Free Report ,Sigma Investments ,Pharmaceuticals Holding Corp ,Tonix Pharmaceuticals Daily ,Nasdaq Tnxp ,Tnxp ,Medical ,Initiated Coverage ,Stocknews Com ,